Scientific information

The Program Committee will review all submitted abstracts. Please note: Presenters of accepted abstracts must pre-register for the Congress by the early-bird deadline. Abstracts must be submitted via this website. Faxed or emailed abstracts will not be considered.

Essential Requirements (Please review)

• Abstracts may be submitted for e-poster presentations.
• There is no limit to the number of abstracts an author may submit.
• Abstracts must be original and must not be or have been published or presented at any other meeting before the Congress.
• All accepted abstracts will be published in the official Congress publications.
• Only abstracts of authors who have paid their registration fees by October 3, 2024 (early bird registration) will be included in the Scientific Program. Please note that at least one of the authors has to be registered for the Congress.
• Each registered author is responsible for his/her registration fee(s), travel, and accommodation costs.
• Abstracts must be submitted by the announced deadline. Abstracts received after the deadline will not be considered.
• All the listed presenters have previewed this abstract and agree to its submission.

Important deadlines

Poster presentation submission deadline EXTENDED: September 30, 2024
Notification deadline: October 23, 2024

Abstract Notifications

Notification regarding abstract acceptance/rejection will be sent to the presenting / corresponding author by October 23, 2024. If you DO NOT receive an e-mail notification regarding your abstract submission by October 23, 2024, please send an e-mail to golob@congressline.hu

ABSTRACT SUBMISSION GUIDELINES

Before you begin, please prepare the following information:

Corresponding Author’s contact details: Email address and phone number.  The Corresponding Author is the person whose contact details were given when creating a new account. This author will receive all communication regarding the abstract status from the organizer.

Author and co-authors’ details: Please enter all authors in the order they should appear in the abstract’s heading. The presenting author should be chosen and marked. Enter the institutional affiliations of all authors. If one author has more institutions, please mark them in the note field.

Presentation type: E-poster presentation

Keywords: You may enter up to 5 keywords that define your abstract.

Abstract title: Limited to 25 words in UPPER CASE

Abstract text: Limited to 250 words (Please be sure not to include extra spaces and symbols as these are included in the word count.)  We recommend using word-processing software (for example, MS Word) to edit your abstract and count the number of words. Typing your text directly into the field is not recommended. If you copy and paste the title and/or body from a Word document, special characters or formatting may not transfer. You may have to replace special characters and/or insert formatting tags using the character palette in the abstract submission website.

Abstracts should clearly state:
Objectives
Methods
Results
Conclusions
References (Author 1, Author 2, Author 3 et al.  Title. Journal Year. Volume: start page-end page)
Acknowledgments – please acknowledge any funding source and contributors to the research.
Figure and Table Legend

Draft abstracts: There is no option to save the abstract as a draft and submit it later. If you do not send your abstract, the information will be deleted. After you submit your abstract, you can still re-enter the submission link at any time to view and edit your abstract until the deadline of September 16, 2024. Please note that abstracts must be SUBMITTED before the deadline to be sent to review for inclusion in the Scientific Program.

Proof: Carefully check the proof of your abstract. Make sure all special characters and formatting are displaying correctly in your proof. If you find errors, return to the abstract title, authors, or body, and make corrections.
It is the author‘s responsibility to submit a correct abstract. Any spelling, grammar, or scientific fact errors will be reproduced as typed by the author.
Upon receipt of your submission, the system will automatically send the corresponding author an email confirmation (with the abstract’s ID and title). Your submission will fail if you do not receive this automatic email message. In that case, please check your browser or the submitted data.

Regulations

Before submitting the abstract, the Corresponding Author will be required to confirm the following:

1. I confirm that I have previewed this abstract and that all information is correct and according to the abstract submission guidelines provided on the Congress website.
2. I accept that the contents of this abstract cannot be modified or corrected after the final submission, and I am aware that it will be published exactly as it was submitted.
3. Submission of the abstract constitutes my consent to all congress publications.
4. I warrant and represent that I am the sole owner or have the rights to all the information and content (‘Content’) provided to NY/NJ Pain Medicine Congress 2024 (Hereafter: ‘Organizers’). The publication of the abstract does not infringe any third-party rights, including, but not limited to, intellectual property rights.
5. I grant the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
6. The Organizers reserve the right to remove from any publication an abstract that does not comply with the above.
7. I hereby confirm that the contact details saved in this system are correct. These details will be used to notify me about the status of the abstract, and I am responsible for informing the other authors about this status.

Conflict of Interest

You will be asked to confirm that you will disclose any conflict of interest in your presentation at the Congress.

Technical Support

If you have any difficulty with the submission process that you cannot resolve yourself, please e-mail golob@congressline.hu

Program Needs Assessment

Interventional Pain management incorporates interventional treatment options for patients to reduce or eliminate the need for chronic conventional medication management (and/or opiate therapy). Interventional treatment options include: spinal cord stimulation, peripheral nerve stimulation, vertebral augmentation, radiofrequency nerve ablation, etc. Since Interventional Pain Management is such a juvenile specialty, very few pain management physicians and anesthesiologists have gone through specific interventional fellowships and residencies. Training in the proper patient selection and utilization of these therapies is limited. Interventionalists need to attend and participate in training programs to receive education and skill-based training in options available for patients.
Additionally, new guidelines are emerging.

It is important for the experts in the field to share the most current information and data available to assist physicians in selecting the right patients and right therapies to improve patient outcomes. Vital topics to be discussed are: New Innovations, Establishing Protocols, Neuromodulation, Complicated Cases, Intrathecal Drug Delivery, Conflicting Evidence and Research. At the conclusion of this meeting, attendees will develop rational guidelines to assist in improving access to care and treatment outcomes for chronic pain patients.

Learning Objectives

• Compare the new and established techniques in interventional pain management to benefit their patients living with chronic or acute pain syndromes.
• Discuss emerging trends and disseminate the latest available data to raise awareness of the high standard of their state-of-the-art medical services.
• Identify educational deficiencies and offer current information and data to enhance patient results in managing chronic or acute pain conditions.
• Present the latest evidence-based medicine to support physicians in selecting appropriate patients for treatments. Provide a format for sharing information among the healthcare team to discuss and enhance care for patients with chronic or acute pain syndromes.
• Review the appropriate utilization of screening options and patient selection to identify those patients at significant risk of developing addictions to controlled substance or those that may abuse, misuse, or divert medications prescribed for chronic pain.

Providership
This CME/CE activity is provided by Albert Einstein College of Medicine – Montefiore Medical Center in joint providership with the New York New Jersey Pain Symposium, Inc.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine–Montefiore Medical Center and New York New Jersey Pain Symposium, Inc. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Albert Einstein College of Medicine- Montefiore Medical Center designates this live activity for a maximum of 28 AMA PRA Category 1 Credits™). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 28 nursing contact hours.  Nurses should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
Albert Einstein College of Medicine-Montefiore Medical Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 28 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME (see above).

Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine – Montefiore Medical Center, NYNJ Pain Symposium, Inc., or the supporting companies. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Special Needs
Albert Einstein College of Medicine – Montefiore Medical Center and the New York New Jersey Pain Symposium, Inc. fully comply with the legal requirements of the Americans with Disabilities Act. If you require special assistance, please submit your request in writing thirty (30) days in advance of the activity, to Bea Golovanova at golob@congressline.hu.

NY/NJ Pain Medicine Congress Organization Officials

Chairman: Sudhir Diwan, MD
Vice Chairs: Scott Woska, MD, Christopher Gharibo, MD
Course Directors: Andrew Kaufman, MD, Robert Tiso, MD, Sayed Emal Wahezi, MD, Latrice Akuamoah, MD

Fellows and Residents Pre-Conference Course Directors

Karina Gritsenko, MD, Sean Li, MD, and Steve Aydin, DO

APP Pre-Conference Course Directors

Kristen Klein, AGNP-C, and Casey Grillo, NP

Cadaver Workshop Directors

Sudhir Diwan, MD
Christopher Gharibo, MD
Scott Woska, MD
Victor Silva, MD

Ultrasound Workshop Directors

George Chang Chien, DO
Jesus Medina, MD
Ashish Shetty, MD
Steve Aydin, MD

Regenerative Medicine Workshop Director

Sudhir Diwan, MD and George Chang Chien, DO

Scientific Program Committee

Chair: Sudhir Diwan, MD
Co-Chair: Sean Li, MD

Members:
Christopher Gharibo, MD
Scott Woska, MD
Brian Durkin, DO
Neel Mehta, MD
Karina Gritsenko, MD
Andrew Kaufman, MD
Steve Aydin, DO
Kristen Klein, AGNP-C
Casey Grillo, NP
Victor Silva, MD
George Chang Chien, DO
Jesus Medina, MD
Ashish Shetty, MD

Office of Administration

Chairman: Sudhir Diwan, MD
COO: Edward Rubin, MD
Administrative Assistant to COO: Cathy Pitbladdo
Executive Director: Sandra Vamos